kras mutation and glutathion G12V mutation-selective requirement for ACSS2 in colorectal adenoma formation: Cell Reports Promising direction for the treatment
Promising direction for the treatment of pancreatic cancers driven by KRAS mutation Der Lab Uncovering new therapeutic targets for a common KRAS mutation behind cancer The Role of KRAS Mutations in Colorectal Cancer: Biological Insights, Clinical Implications, and Future Therapeutic Perspectives Targeting KRAS: from metabolic regulation to cancer treatment Molecular Cancer Springer Nature Link Selective killing of cancer cells harboring mutant RAS by concomitant inhibition of NADPH oxidase and glutathione biosynthesis Cell Death & Disease Interplays of glucose metabolism and KRAS mutation in pancreatic ductal adenocarcinoma Cell Death & Disease
Pay in 4 interest-free payments of $5.78 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10





